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A 94‐ year‐ old man with NYHA class III heart failure who underwent transcatheter aortic valve replacement (TAVR) with a 34  mm Evolut R self‐ expandable heart valve (Medtronic, Inc) for severe aortic stenosis (AS) 3 \_months prior presentation, presented with dyspnea and confusion. An unenhanced computed tomography of the chest showed the aortic prosthetic valve in place along a prominent aneurysmal dilation of the ascending thoracic aorta and internal displacement of mural calcifications toward the aortic lumen, suggestive of a Stanford type A aortic dissection (Figure [1](#ccr32353-fig-0001){ref-type="fig"}, panel A, B). A transthoracic echocardiogram showed a severely dilated aorta with a complex intimal flap consistent with an aortic dissection (Figure [1](#ccr32353-fig-0001){ref-type="fig"}, panel C, D). Due to his advanced age and high surgical risk, his family decided to forgo any surgical intervention and transition care toward comfort care.

![(A) Axial and, (B) Sagittal view of an unenhanced computed tomography (CT) of the chest showing a prominent aneurysmal dilation of the thoracic aorta with severe atherosclerotic vascular calcifications and internal displacement of mural calcifications toward the aortic lumen (arrows), suggestive of a Stanford type A aortic dissection; and demonstration of a prosthetic aortic valve in appropriate location (black arrowheads). AA, aortic arch; AS, ascending aorta; DS, descending aorta. Transthoracic echocardiogram, (C) parasternal short‐ axis view, and (D) parasternal long‐ axis view showing a severely dilated ascending aorta with a complex intimal flap (arrow) that divides the aorta into two, true and false, lumen; and (D) demonstrates the true lumen by color Doppler (asterisks) and a pericardial effusion. FL, false lumen; PE, pericardial effusion; TL, true lumen](CCR3-7-1821-g001){#ccr32353-fig-0001}

Transcatheter aortic valve replacement has replaced surgical aortic valve replacement as the treatment of choice for symptomatic severe AS in patients at high surgical risk. Aortic dissection (AD) is a life‐ threatening complication of TAVR, reported in 0.6%‐ 1.9% of cases.[1](#ccr32353-bib-0001){ref-type="ref"} Conventionally, the treatment of AD is emergent open surgical repair; however, its management in TAVR patients is challenging because they are already at high operative risk. More recently, less invasive procedures have gained popularity. Yet, the lack of evidence‐ based data and guidelines on its management makes it a treatment dilemma.
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